Metastatic Or Advanced Malignant Solid Tumors clinical trials

Explore recruiting metastatic or advanced malignant solid tumors clinical trials.

Recruiting metastatic or advanced malignant solid tumors studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metastatic Or Advanced Malignant Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Trial to assess the safety and antitumor activity of GEN1057 on malignant solid tumors

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Study of GEN1106 in Participants with Solid Tumors

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Metastatic Or Advanced Malignant Solid Tumors trials by city

Metastatic Or Advanced Malignant Solid Tumors clinical trials

Recruiting metastatic or advanced malignant solid tumors studies right now

Combination of CAR-DC Vaccine and ICIs in Malignant Tumors

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC

A Study of MT027 in Patients with Pleural Malignant Tumors

AMT-253 in Patients With Advanced Solid Tumours

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors

Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

A Dose Escalation and Dose Expansion Trial of WTX212A in the Treatment of Patients with Advanced Malignant Tumors

TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors

Also recruiting in Europe

Trial to assess the safety and antitumor activity of GEN1057 on malignant solid tumors

A Study of GEN1106 in Participants with Solid Tumors

Metastatic Or Advanced Malignant Solid Tumors trials by city

Other conditions